Sight OLO is the first device to receive FDA clearance for a 5-part differential CBC test directly from a fingerstick sample, requiring 5% of the minimum blood volume needed for traditional lab equipment and still providing the same quality of lab-grade results with no maintenance. OLO digitizes blood with only 2 drops of a finger stick or venous sample and provides lab-grade CBC results in minutes.